Showing results (301-310 of 319) with videos related to

Sort By:
Pageof 32
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 1, 2019
Sorafenib in Hepatopulmonary Syndrome: A Randomized, Double-Blind, Placebo-Controlled TrialSteven M Kawut, Susan S Ellenberg, Michael J Krowka, et al.
Protein Science : a Publication of the Protein Society|November 11, 2021
Structure-activity relationship studies of allosteric inhibitors of EYA2 tyrosine phosphataseJothi Anantharajan, Nithya Baburajendran, Grace Lin, et al.
Journal of Clinical Microbiology|December 20, 2013
Predicting extensively drug-resistant Mycobacterium tuberculosis phenotypes with genetic mutationsTimothy C Rodwell, Faramarz Valafar, James Douglas, et al.
Cornea|November 15, 2017
Chemical Burns of the Eye: The Role of Retinal Injury and New Therapeutic PossibilitiesClaes H Dohlman, Fabiano Cade, Caio V Regatieri, et al.
American Heart Journal Plus : Cardiology Research and Practice|December 11, 2025
A Pragmatic Trial Evaluating the Impact of the Anumana Clinical Decision Support Tool for Guideline-Directed Management of Heart Failure (ACT-HF): Clinical trial design and methodsFrancisco Lopez-Jimenez, Heather M Alger, Sarah P Hackett, et al.
Elife|August 31, 2021
Adult stem cell-derived complete lung organoid models emulate lung disease in COVID-19Courtney Tindle, MacKenzie Fuller, Ayden Fonseca, et al.
European Journal of Heart Failure|March 18, 2015
Impact of surgical ventricular reconstruction on sphericity index in patients with ischaemic cardiomyopathy: follow-up from the STICH trialJin-Oh Choi, Richard C Daly, Grace Lin, et al.
Molecular Cancer Therapeutics|July 10, 2019
Structural and Functional Analyses of an Allosteric EYA2 Phosphatase Inhibitor That Has On-Target Effects in Human Lung Cancer CellsJothi Anantharajan, Hengbo Zhou, Lingdi Zhang, et al.
Hepatology (Baltimore, Md.)|May 15, 2020
Estrogen Signaling and Portopulmonary Hypertension: The Pulmonary Vascular Complications of Liver Disease Study (PVCLD2)Nadine Al-Naamani, Michael J Krowka, Kimberly A Forde, et al.
Pageof 32